CDNA - Company ID 0001217234
The table below shows CareDx, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $139.36M | $131.95M | $117.70M | $100.06M | $86.68M | $84.69M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $21.32M | $22.38M | $21.42M | $16.77M | $16.83M | $18.52M |
CareDx, Inc. reported annual revenue of $379.81M for fiscal year 2025. That is up 13.8% from $333.79M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $40.63M (FY 2016) to $379.81M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $37.99M |
| $40.91M |
| $30.48M |
| $28.43M |
| $27.68M |
| $22.77M |
| Operating income | $8.11M | $113.22M | $1.20M | -$246.00K | -$11.12M | -$13.37M |
| Income tax | -$8.60M | $3.88M | -$32.01K | -$15.00K | -$117.00K | $58.00K |
| Net income | $19.29M | $110.64M | $2.81M | $1.68M | -$8.57M | -$10.35M |
| EPS (diluted) | $0.35 | $2.07 | $0.05 | $0.03 | -$0.16 | -$0.19 |